Cargando…

IS THERE ANY DIFFERENCE IN THE PROGNOSIS FOR PATIENTS WITH PRIMARY OSTEOSARCOMA WITH A POOR RESPONSE TO NEOADJUVANT CHEMOTHERAPY BETWEEN HUVOS GRADES I AND II?

Would there be any difference in the prognosis for patients who presented, for example, 8% or 88% tumor necrosis induced by chemotherapy, even though both individuals were considered to be poor responders? The aim of this study was to compare the prognoses for different histological grades (Huvos gr...

Descripción completa

Detalles Bibliográficos
Autores principales: Bispo Júnior, Rosalvo Zósimo, Camargo, Olavo Pires de
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4799283/
https://www.ncbi.nlm.nih.gov/pubmed/27027032
http://dx.doi.org/10.1016/S2255-4971(15)30256-1